STAAR Surgical Co
SWB:SR3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
STAAR Surgical Co
SWB:SR3
|
US |
|
Cresco Ltd
OTC:CEJOF
|
JP |
|
N
|
New Zealand Energy Corp
OTC:NZERF
|
NZ |
|
Harmonic Drive Systems Inc
F:K3R
|
JP |
|
B
|
Blueprint Medicines Corp
F:2L9
|
US |
|
Mpact Ltd
OTC:MPPTF
|
ZA |
|
F
|
Furukawa Electric Co Ltd
XMUN:FKA
|
JP |
|
China BlueChemical Ltd
OTC:CBLUY
|
CN |
|
Z
|
Zenith Minerals Ltd
F:ZCB
|
AU |
|
I
|
Infocom Corp
OTC:IFFOF
|
JP |
|
F
|
Felix Gold Ltd
OTC:FXGDF
|
AU |
|
Aion Therapeutic Inc
OTC:ANTCF
|
CA |
|
X
|
Xinjiang Xinxin Mining Industry Co Ltd
XMUN:33X1
|
CN |
|
Calidus Resources Ltd
F:HFU1
|
AU |
Wall St Price Targets
SR3 Price Targets Summary
STAAR Surgical Co
According to Wall Street analysts, the average 1-year price target for
SR3 is 27.87 EUR with a low forecast of 19.23 EUR and a high forecast of 39.98 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SR3's stock price target?
Price Target
27.87
EUR
According to Wall Street analysts, the average 1-year price target for
SR3 is 27.87 EUR with a low forecast of 19.23 EUR and a high forecast of 39.98 EUR.
What is the Revenue forecast for STAAR Surgical Co?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for STAAR Surgical Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 5 years is 17%.